Shares of Vascular Solutions Inc. (NASDAQ:VASC) reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $47.75 and last traded at $47.70, with a volume of 28,117 shares. The stock had previously closed at $47.07.

Several equities analysts have recently weighed in on the company. Sidoti downgraded Vascular Solutions from a “buy” rating to a “neutral” rating and set a $47.00 target price on the stock. in a research report on Tuesday, July 12th. Piper Jaffray Cos. reissued an “overweight” rating and set a $45.00 target price (up previously from $44.00) on shares of Vascular Solutions in a research report on Wednesday, April 27th. Zacks Investment Research raised Vascular Solutions from a “hold” rating to a “buy” rating and set a $39.00 target price on the stock in a research report on Thursday, April 28th. TheStreet raised Vascular Solutions from a “hold” rating to a “buy” rating in a research report on Monday, July 25th. Finally, Canaccord Genuity reissued a “buy” rating on shares of Vascular Solutions in a research report on Wednesday, August 10th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $47.38.

The stock’s 50-day moving average price is $44.59 and its 200-day moving average price is $36.51. The firm has a market capitalization of $835.72 million and a P/E ratio of 88.48.

Vascular Solutions (NASDAQ:VASC) last issued its quarterly earnings results on Monday, July 25th. The medical device company reported $0.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.03. During the same quarter in the prior year, the company posted $0.29 EPS. The business had revenue of $41.20 million for the quarter, compared to analysts’ expectations of $41.40 million. The business’s revenue for the quarter was up 9.7% compared to the same quarter last year. On average, equities analysts expect that Vascular Solutions Inc. will post $1.24 earnings per share for the current year.

In other Vascular Solutions news, VP William Rutstein sold 10,011 shares of the stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $46.26, for a total transaction of $463,108.86. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Howard Root sold 34,418 shares of the stock in a transaction that occurred on Tuesday, May 24th. The stock was sold at an average price of $39.05, for a total value of $1,344,022.90. Following the transaction, the chief executive officer now owns 348,340 shares in the company, valued at approximately $13,602,677. The disclosure for this sale can be found here.

An institutional investor recently raised its position in Vascular Solutions stock. Argent Capital Management LLC raised its position in Vascular Solutions Inc. (NASDAQ:VASC) by 117.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 97,035 shares of the medical device company’s stock after buying an additional 52,400 shares during the period. Argent Capital Management LLC owned approximately 0.56% of Vascular Solutions worth $3,337,000 as of its most recent SEC filing.

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.